Enoxaparin Sodium Injection
Product Images NDC 63323-607

Product Visual Gallery

This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 63323-607). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Enox Fk Nova 01)

An instructional illustration showing hands holding a syringe, demonstrating the technique of pulling back or pushing forward the plunger. The image likely depicts the process of preparing or administering an injection, relevant to subcutaneous injection procedures.*

FDA Label Image

Figure B (Enox Fk Nova 02)

An instructional illustration showing a hand holding a syringe for subcutaneous injection, with an arrow indicating the direction of injection into the skin of the opposite hand. This image demonstrates proper administration technique for Enoxaparin Sodium injection.*

FDA Label Image

Figure C (Enox Fk Nova 03)

An instructional illustration showing a hand administering a subcutaneous injection with a syringe. The syringe is held at an angle to the skin, with an arrow indicating the direction of injection beneath the skin surface.*

FDA Label Image

Figure D (Enox Fk Nova 04)

An instructional illustration showing a hand holding a syringe with a blue arrow indicating a twisting or unlocking motion near the base of the needle. The syringe appears to be for injection, consistent with subcutaneous administration of enoxaparin sodium injection.*

FDA Label Image

Figure E (Enox Fk Nova 05)

An instructional illustration showing a gloved hand dropping a used syringe into a red biohazard sharps disposal container with a flip-top lid. The image emphasizes safe disposal of injection equipment.*

FDA Label Image

Chemical Structure (Enox Fk Nova 06)

Chemical structure diagram depicting a polymer chain with repeating sugar and amino groups, consistent with the molecular structure of enoxaparin sodium, the active ingredient in Enoxaparin Sodium injection by Fresenius Kabi USA, LLC.*

FDA Label Image

Chemical Structure (Enox Fk Nova 07)

Chemical structure of enoxaparin sodium, depicting its molecular components with sodium (Na), oxygen, and nitrogen atoms arranged in a polysaccharide backbone characteristic of low molecular weight heparins.*

FDA Label Image

Figure 1 (Enox Fk Nova 08)

A forest plot chart displaying relative risk comparisons between enoxaparin sodium and unfractionated heparin (UFH) across patient subgroups. It includes sample sizes and numerical values of risk percentages and reduction for subgroups such as sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent type, time to treatment, and PCI within 30 days. The plot visually represents enoxaparin's relative risk as better or worse compared to UFH.*

FDA Label Image

Figure 2 (Enox Fk Nova 09)

A Kaplan-Meier hazard distribution function chart comparing time to death or myocardial reinfarction over 30 days for Enoxaparin versus Unfractionated Heparin (UFH). The graph shows the hazard function rising over time for both treatments, with Enoxaparin consistently lower than UFH. An inset chart displays similar data over one year. The chart includes a log-rank test result indicating statistical significance (p<0.0001 for 30 days, p=0.0111 for 1 year). Below the graph, the number of patients at risk is provided for both treatment groups at various time points.*

FDA Label Image

Parts Image (Enox Fk Nova 10)

An instructional diagram showing an injection syringe used for Enoxaparin Sodium subcutaneous injection. The left side illustrates the syringe before use with labeled parts including the plunger rod, needle, and needle cap. The right side shows the syringe after use, with the plunger rod depressed and a protective sleeve covering the needle.*

FDA Label Image

Figure A (Enox Fk Nova 11)

An illustration showing the components included with an Enoxaparin Sodium prefilled syringe injection kit. Items labeled include the prefilled syringe, a cotton ball or gauze, a sharps disposal container, an alcohol wipe, and a small adhesive bandage.*

FDA Label Image

Figure B (Enox Fk Nova 12)

An instructional illustration showing hands removing a syringe from a sealed blister pack. The syringe appears prefilled and is held horizontally above the opened packaging, indicating the proper method for accessing the injection product.*

FDA Label Image

Figure C (Enox Fk Nova 13)

An illustration of a prefilled syringe of Enoxaparin Sodium injection showing the syringe structure including the plunger, barrel, needle cap, and an indicated location for the expiration date on the barrel.*

FDA Label Image

Figure D (Enox Fk Nova 14)

Illustration showing a prefilled subcutaneous injection syringe containing Enoxaparin Sodium as a clear liquid. The image highlights the syringe components and the clear appearance of the liquid medication inside.*

FDA Label Image

Figure E (Enox Fk Nova 15)

Illustration showing the recommended subcutaneous injection sites for Enoxaparin Sodium injection, depicting the left and right lower abdominal areas as injection locations.*

FDA Label Image

Figure F (Enox Fk Nova 16)

An instructional illustration showing a hand holding an alcohol swab and cleaning the skin on a person's lower abdomen, demonstrating site preparation for a subcutaneous injection.*

FDA Label Image

Figure G (Enox Fk Nova 17)

Illustration showing two hands preparing an injection syringe by removing or attaching the needle cap. Arrows indicate the direction of pulling the needle cover off or placing it back on, demonstrating a step in medication administration procedure.*

FDA Label Image

Figure H (Enox Fk Nova 18)

An instructional illustration showing a hand holding a syringe filled with medication. The diagram highlights the step to set the dose by pushing down the plunger to the marked level, accompanied by an arrow pointing downward and the text 'Set your dose.' This image aids in proper dosing technique for a subcutaneous injection.*

FDA Label Image

Figure I (Enox Fk Nova 19)

An instructional illustration showing a hand pinching the skin of the abdomen, likely demonstrating the typical subcutaneous injection site for an enoxaparin sodium injection. The image focuses on the abdominal area and the thumb and fingers performing the pinch.*

FDA Label Image

Figure J (Enox Fk Nova 20)

An instructional diagram showing a hand administering a subcutaneous injection with a syringe into the abdomen at a 90-degree angle. The illustration emphasizes insertion technique for the Enoxaparin Sodium injection.*

FDA Label Image

Figure K (Enox Fk Nova 21)

An instructional illustration demonstrating the subcutaneous injection technique. The image shows a person holding a syringe with one hand while pinching the skin on the abdomen with the other hand, preparing to inject medication. An arrow indicates the direction of the injection into the skin fold.*

FDA Label Image

Figure L (Enox Fk Nova 22)

An instructional illustration showing a hand holding a syringe with a needle directed towards the abdomen for subcutaneous injection. Another hand is shown pinching the skin, indicating proper injection site preparation, commonly associated with Enoxaparin Sodium subcutaneous injection.*

FDA Label Image

Figure M (Enox Fk Nova 23)

An instructional diagram showing a hand holding an injection device for Enoxaparin Sodium, indicating a 'click' action to remove or engage the protective sleeve on the injection syringe prior to subcutaneous administration.*

FDA Label Image

Figure N (Enox Fk Nova 24)

An instructional illustration showing a hand disposing of a syringe with needle cap into a labeled sharps disposal container. The syringe and needle cap are labeled to indicate correct disposal procedure, promoting safe handling of injection materials.*

FDA Label Image

Principal Display Panel (30 mg/0.3 mL Syringe Carton)

Packaging label for Enoxaparin Sodium Injection 30 mg/0.3 mL by Fresenius Kabi USA, LLC. The label indicates single-dose syringes with an automatic safety device for subcutaneous injection. The package contains ten 0.3 mL syringes and includes usage directions with illustrations for safe syringe use and disposal.*

FDA Label Image

Principal Display Panel (40 mg/0.4 mL Syringe Carton)

Packaging label for Enoxaparin Sodium Injection, 40 mg/0.4 mL, subcutaneous injection in single-dose syringes with automatic safety device. Contains ten 0.4 mL syringes. Manufactured by Fresenius Kabi USA, LLC. Label includes dosage strength, product name, barcodes, and safety usage instructions.*

FDA Label Image

Principal Display Panel (60 mg/0.6 mL Syringe Carton)

Packaging label for Enoxaparin Sodium Injection 60 mg/0.6 mL, single-dose syringes with automatic safety device for subcutaneous injection. The label states Rx only, contains ten 0.6 mL syringes, and is manufactured for Fresenius Kabi USA, LLC. It includes barcodes, product name, strength, dosage form, and usage instructions with illustrations.*

FDA Label Image

Principal Display Panel (80 mg/0.8 mL Syringe Carton)

Packaging label for Enoxaparin Sodium Injection 80 mg/0.8 mL single dose syringes with automatic safety device for subcutaneous injection. The carton contains ten 0.8 mL syringes. Labeler is Fresenius Kabi USA, LLC. The label includes usage directions with illustrations and storage warnings.*

FDA Label Image

Principal Display Panel (100 mg/1 mL Syringe Carton)

Packaging label for Enoxaparin Sodium Injection 100 mg/1 mL by Fresenius Kabi USA, LLC. The label indicates a box containing ten 1 mL single-dose syringes with an automatic safety device for subcutaneous injection. Instructions and warnings are included, along with barcodes and serialization areas. The brand Novaplus is also displayed.*

FDA Label Image

Principal Display Panel (300 mg/3 mL Vial Carton)

Packaging label for Enoxaparin Sodium Injection 300 mg/3 mL (100 mg/mL) by Fresenius Kabi USA, LLC. The box highlights the product name, strength, dosage form as injection for subcutaneous or intravenous use, multiple dose vial, and includes storage instructions and warnings. The label features red, blue, and white colors with barcodes and the NOVAPLUS trademark.*

FDA Label Image

Principal Display Panel (120 mg/0.8 mL Syringe Carton)

Packaging label for Enoxaparin Sodium Injection 120 mg/0.8 mL, a subcutaneous injection by Fresenius Kabi USA, LLC. The label specifies single dose syringes with an automatic safety device and includes directions for use and storage instructions. The box contains ten 0.8 mL prefilled syringes.*

FDA Label Image

Principal Display Panel (150 mg/1 mL Syringe Carton)

Packaging label for Enoxaparin Sodium Injection 150 mg/1 mL in single-dose syringes with automatic safety device for subcutaneous injection. The label shows the product name, strength, dosage form, Rx only status, package size of ten 1 mL syringes, and manufacturer Fresenius Kabi USA, LLC. It includes usage directions and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.